When CardioGenics completes their financing, my due diligence indicates they are close, the Company will also announce the quick restart of the Beta Site testing at Wayne State. IMO, the 100 additional patients needed to complete the study should be tabulated within two months of the restart. The stock should be accumulated at these "bargain basement" prices for a major upside move.